Impact of perceived innovation characteristics on adoption of pharmacy-based in-house immunization services

International Journal of Pharmacy Practice

Volumn 17, Issue 1, 2009, Pages 39-46

  Westrick, Salisa C ^a   Mount, Jeanine K ^b  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Adoption; Characteristic; Diffusion; Innovation; Pharmacy

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DECISION MAKING; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH PRACTITIONER; HUMAN; IMMUNIZATION; INFORMATION PROCESSING; LEADERSHIP; MEDICAL RESEARCH; PHARMACEUTICAL CARE; PHARMACIST; PREDICTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; UNITED STATES;

EID: 59149101025     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.17.1.0006     Document Type: Article

References (65)

1. Babar ZU et al. A preliminary study on the effect of pharmacist counseling on awareness of and willingness to quit smoking in Malaysian population. Pharm World Sci 2007; 29(3): 101-103.
2. Noyce PR. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother 2007; 41(5): 861-868.
3. Soon JA et al. Effects of making emergency contraception available without a physician's prescription: a population-based study. Can Med Assoc J 2005; 172(7): 878-883.
4. Kolor B. Patient education and treatment strategies implemented at a pharmacist-managed hepatitis C virus clinic. Pharmacotherapy 2005; 25(9): 1230-1241.
5. Melchior SC et al. The role of the pharmacist in the Brazilian AIDS Program (CPS-P-215). International Pharmaceutical Federation World Congress, 2002; 62(80).
6. Day C. How HIV is affecting breastfeeding practices: what should the pharmacist advise? S Afr Pharm J 1999; 66: 167.
7. Cramp GJ et al. An evaluation of a rural community pharmacy-based smoking-cessation counseling and nicotine replacement therapy initiative. Int J Pharm Pract 2007; 15(2): 113-121.
8. Edwards D et al. Pharmacists' role in smoking cessation: an examination of current practice and barriers to service provision. Int J Pharm Pract 2006; 14(4): 315-317.
9. Babb VJ, Babb J. Pharmacist involvement in healthy people 2010. J Am Pharm Assoc 2003; 43(1): 56-60.
10. Ernst ME et al. Implementation of a community pharmacy-based influenza vaccination program. J Am Pharm Assoc 1997; 37(5): 570-580.
11. Hogue M, Benske JA. Pharmacists as immunization advocates. Wis Pharm 1997; 66: 82-85.
12. Grabenstein JD et al. Effect of vaccination by community pharmacists among adult prescription recipients. Med Care 2001; 34(4): 340-348.
13. Madhavan SS et al. Pharmacists and immunizations: a national survey. J Am Pharm Assoc 2001; 41(1): 32-45.
14. Bearden DT, Holt T. Statewide impact of pharmacist-delivered adult influenza vaccinations. Am J Prev Med 2005; 29(5):450-452.
15. Pedersen CA et al. Pharmacists' opinions regarding level of involvement in emergency preparedness and response. J Am Pharm Assoc 2003; 43(6): 694-701.
16. Ukens C. Uncle Sam wants R.Ph.s for disaster relief teams. Drug Topics 2004; 148(2): 31.
17. Fromer DB et al. Pharmacists' self-assessments regarding emergency preparedness activities in Kansas. J Pharm Technol 2007; 23(2): 75-78.
18. Hudmon K, Berger B. Pharmacy applications of the transtheoretical model in smoking cessation. Am J Health Syst Pharm 1995; 52(3): 282-287.
19. Dent LA et al. Pharmacist-managed tobacco cessation program in veterans health administration community-based outpatient clinic. J Am Pharm Assoc 2004; 44(6): 700-715.
20. Fuller CM et al. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health 2007; 97(1): 117-124.
21. Deibert RJ et al. Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003. Am J Public Health 2006; 96(8): 1347-1353.
22. Marks RW et al. Encouraging pharmacy sale and safe disposal of syringes in Seattle, Washington. J Am Pharm Assoc 2002; 42(6): S26-S27.
23. Heron MP. Deaths: leading causes for 2004. Natl Vital Stat Rep 2007; 56(5): 8.
24. Bratzler DW et al. Failure to vaccinate Medicare inpatients: a missed opportunity. Arch Intern Med 2002; 162: 2349-2356.
25. United States Department of Health and Human Services. Healthy People 2010: With Understanding and Improving Health and Objectives for Improving Health, vol. 2, 2nd edn. Washington DC: US Government Printing Office, 2000.
26. National Vaccine Advisory Committee. The measles epidemics: the problems, barriers and recommendations. JAMA 1991; 266(11): 1547-1522.
27. Savino LB. Your pharmacy and immunizations. America's Pharm 1998; 120(7): 49-53.
28. Chamnanmoh S. Adoption of immunization services in pharmacies. Madison, Wisconsin: University of Wisconsin-Madison, 2004 (dissertation).
29. Steyer TE et al. The role of pharmacists in the delivery of influenza vaccinations. Vaccine 2004; 22(8): 1001-1006.
30. Hogue MD et al. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc 2006; 46(2): 168-181.
31. Kim M et al. Pharmacist Provision of Immunizations in 2006: Analysis of State Laws in the United States. Kansas City, MO: National Immunization Conference, 2007.
32. Anon. New law lets pharmacists administer flu vaccinations. The New York Times 2008; September 6: B4.
33. Kamal KM et al. Pharmacy and immunization services: pharmacists' participation and impact. J Am Pharm Assoc 2003; 43(4): 470-487.
34. Westrick SC et al. Pharmacy stages of involvement in pharmacy-based immunization services: results from a 17-state survey. J Am Pharm Assoc 2008; 48(6): 764-773.
35. Rogers EM. Diffusion of Innovation, 5th ed. New York: Free Press, 2003.
36. Gladwell M. The Tipping Point: How Little Things can Make a Big Difference. Boston, MA: Back Bay Books, 2002.
37. Zey M. Rational Choice Theory and Organizational Theory: A Critique. Thousand Oaks, CA: Sage, 1998.
38. Barringer MW, Milkovich GT. A theoretical exploration of the adoption design of flexible benefit plans: a case of human resource innovation. Acad Manage Rev 1998; 23(2): 305-324.
39. Flanagin AJ. Social pressures on organizational website adoption. Hum Commun Res 2000; 26(4): 618-646.
40. Meyer JW et al. Institutional and Technical Sources of Organizational Structure: Explaining the Structure of Educational Organizations. Philadelphia, PA: Temple University Press, 1981.
41. Downs GW, Mohr LB. Conceptual issues in the study of innovation. Adm Sci Q 1976; 21(4): 700-714.
42. Scott WR. Innovation in medical care organizations: a synthetic review. Med Care Rev 1990; 47(2): 165-192.
43. Tornatzky LG, Klein KJ. Innovation characteristics and innovation adoption implementation: a meta analysis of findings. IEEE Transactions on Engineering Management 1982; 29: 28-45.
44. Giegerich A. Give it a shot. Natl Assoc Retail Drug J 1999; 121: 17-21.
45. Morton MR et al. Pharmacist impact on pneumococcal vaccination rates in long-term care facilities. Am J Hosp Pharm 1988; 45: 73.
46. Rosenbluth SA et al. Pharmacy immunization partnerships: a rural model. J Am Pharm Assoc 2001; 41(1): 100-107.
47. D'Heilly S et al. Safety and acceptability of pneumococcal vaccinations administered in nontraditional settings. Am J Infect Control 2002; 30(5): 261-268.
48. Meyer AD, Goes JB. Organizational assimilation of innovations: a multilevel contextual analysis. Acad Manage J 1988; 31(4): 897-923.
49. Goldman KD. Perceptions of a health education innovation as predictors of implementation: the march of dimes campaign for healthier babies. Health Educ Behav 1994; 21(4): 433-445.
50. Grover V. An empirically derived model for the adoption of customer-based interorganizational systems. Dec Sci 1993; 24(3): 603-640.
51. Dewar RD, Dutton JE. The adoption of radical and incremental innovations: an empirical analysis. Manage Sci 1986; 32(11): 1422-1433.
52. Greenhalgh T et al. Diffusion of Innovations in Health Service Organizations: a Systematic Literature Review. Malden, MA: Blackwell Publishing, 2005.
53. Cooper RB, Zmud RW. Information technology implementation research: a technological diffusion approach. Manage Sci 1990; 36(2): 123-139.
54. Dillman DA. Design and administration of mail surveys. Annu Rev Sociol 1991; 17: 225-249.
55. Dillman DA. Mail and Internet Surveys: the Tailored Design Method, 2nd edn. New York: Wiley & Sons, 1999.
56. Westrick SC, Mount JK. Evaluating telephone follow-up of a mail survey of community pharmacies. Res Social Adm Pharm 2007; 3: 160-182.
57. Groves RM et al. The role of topic interest in survey participation decisions. Public Opin Q 2004; 68(1): 2-31.
58. Smith FJ, Weidner D. Threathening and violent incidents in community pharmacies: an investigation of the frequency of serious and minor accidents. Int J Pharm Pract 1996; 4: 136-144.
59. Solberg LI et al. Non-response bias: does it affect measurement of clinician behavior. Med Care 2002; 40(4): 347-352.
60. Fowler FJ et al. Using telephone interviews to reduce nonresponse bias to mail surveys of health plan members. Med Care. 2002; 40(3): 190-200.
61. Westrick SC, Mount JK. Effects of repeated callbacks on response rate and nonresponse bias: results from a 17-state pharmacy survey. Res Social Adm Pharm 2008; 4(1): 46-58.
62. Kimberly JR, Evanisko M. Organizational innovation: the influence of individual, organizational, and contextual factors on hospital adoption of technological and administrative innovations. Acad Manage J 1981; 24(4): 689-713.
63. Nunnally JC, Bernstein IH. Psychometric Theory, 3rd edn. New York: McGraw-Hill, 1994.
64. Allison PD. Logistic Regression Using the SAS System: Theory and Application. Cary, NC: SAS Institute, 1999.
65. Westrick SC, Breland ML. Sustainability of pharmacy-based innovations: the case of in-house immunization services. J Am Pharm Assoc 2009 (in press).